Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 16.
doi: 10.1007/s12328-025-02184-1. Online ahead of print.

Chronic lymphocytic leukemia complicated by non-cirrhotic portal hypertension: an autopsy case report

Affiliations

Chronic lymphocytic leukemia complicated by non-cirrhotic portal hypertension: an autopsy case report

Akiri Hiraide et al. Clin J Gastroenterol. .

Abstract

Portal hypertension typically occurs in cirrhosis but can rarely develop in the absence of hepatic fibrosis, particularly in hematologic malignancies such as chronic lymphocytic leukemia (CLL). We report a 70-year-old man with CLL who developed portal hypertension, presenting with massive splenomegaly, esophageal variceal rupture, and refractory ascites. He was initially diagnosed with alcohol-related cirrhosis based on a history of alcohol use and elevated liver stiffness on elastography. Chemotherapy had been discontinued due to cerebral hemorrhage and cytopenia. Ascites was refractory to and intolerant of diuretics and was worsened by renal dysfunction due to spontaneous bacterial peritonitis. After resolution of peritonitis, partial splenic artery embolization (PSE) was performed to relieve portal hypertension. Although ascites improved post-PSE, the patient developed a severe infection and died. Autopsy revealed no cirrhosis or hepatic fibrosis; instead, portal hypertension was attributed to CLL cell infiltration leading to splenomegaly and portal venous obstruction. This case underscores the need to consider hematologic malignancies as potential causes of non-cirrhotic portal hypertension. While PSE may offer symptomatic relief, the risk of fatal infection must be carefully weighed in patients with hematological malignancies. Histologic confirmation remains critical for accurate diagnosis in atypical presentations of portal hypertension.

Keywords: Autopsy; Chronic lymphocytic leukemia; Non-cirrhotic portal hypertension; Partial splenic embolization; Splenomegaly.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflicts of interest: The authors declare no conflicts of interest related to the study. Human/animal rights: All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Informed consent: Informed consent was obtained from the patient’s family for being included in the study.

Similar articles

References

    1. Yoshiji H, Nagoshi S, Akahane T, et al. Evidence-based clinical practice guidelines for Liver Cirrhosis 2020. J Gastroenterol. 2021;56:593–619. - PubMed - PMC
    1. Khanna R, Sarin SK. Non-cirrhotic portal hypertension - diagnosis and management. J Hepatol. 2014;60:421–41. - PubMed
    1. de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022;76:959–74. - PubMed
    1. Dietrich CF, Bamber J, Berzigotti A, et al. EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version). Ultraschall Med. 2017;38:e16–47. - PubMed
    1. Erten N, Saka B, Caliskan YK, et al. Acute renal failure due to leukaemic infiltration in chronic lymphocytic leukemia: case report. Int J Clin Pract Suppl. 2005;147:53–5.

LinkOut - more resources